Stay updated with breaking news from Evidence Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Association Files Formal Request for Reconsideration of National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the...
Congressman John Joyce, M.D. (PA-13) and Congresswoman Nanette Barragán (CA-44), recently introduced legislation to ensure greater access to Alzheimer’s Disease treatments for American seniors.
On April 7, the Centers for Medicare & Medicaid Services (CMS) released its highly anticipated final National Coverage Determination (NCD) for Aduhelm and other similar therapies in the...
Medicare finalized its plan to restrict coverage for a controversial, pricey Alzheimer’s drug to patients participating in clinical trials.
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB). Such investors are...